Neda Laiteerapong to Hypoglycemic Agents
This is a "connection" page, showing publications Neda Laiteerapong has written about Hypoglycemic Agents.
Connection Strength
2.422
-
Glycemic Control in Nonpregnant Adults With Type 2 Diabetes. JAMA. 2018 06 19; 319(23):2430-2431.
Score: 0.524
-
Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018 02 06; 168(3):170-178.
Score: 0.506
-
Physician perspectives on de-intensifying diabetes medications. Medicine (Baltimore). 2016 Nov; 95(46):e5388.
Score: 0.468
-
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Ann Intern Med. 2023 04; 176(4):eL230007.
Score: 0.183
-
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
Score: 0.177
-
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med. 2022 02; 37(2):415-438.
Score: 0.164
-
Use and Discontinuation of Insulin Treatment Among Adults Aged 75 to 79 Years With Type 2 Diabetes. JAMA Intern Med. 2019 12 01; 179(12):1633-1641.
Score: 0.145
-
Guidelines on Glycemic Targets for Persons With Type 2 Diabetes-Reply. JAMA. 2018 11 13; 320(18):1937-1938.
Score: 0.135
-
5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine. Diabetes Obes Metab. 2024 Feb; 26(2):463-472.
Score: 0.047
-
Glycemic control and diabetes complications across health status categories in older adults treated with insulin or insulin secretagogues: The Diabetes & Aging Study. J Am Geriatr Soc. 2023 12; 71(12):3692-3700.
Score: 0.047
-
Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
Score: 0.026